Topic

Insilico

Technology & Infrastructure · Models & LLMs

AI-Designed Drug Shows Signs of Lowering Biological Age in Early Clinical Study

Insider Brief An artificial intelligence-designed drug for a deadly lung disease produced protein changes associated with lower biological age, offering early evidence that AI-discovered medicines could be evaluated for effects beyond the diseases they

7 Sep 2026 · 8 min read

Technology & Infrastructure · Models & LLMs

Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery

24 Aug 2026

Business & Markets

AI Insider’s The Week in Review: OpenAI for Government, G7 Leaders, Pope Address AI, Amazon to Cut Jobs Amid AI Adoption, Plus Companies Raise Funds for Drug Discovery, Automation Across Industries

20 Jun 2025

Business & Markets · Enterprise

AI-designed TNIK Inhibitors Could Treat a Range of Aging-Related Diseases, From Fibrosis to Alzheimer’s.

29 May 2024

Insilico

AI-Designed Drug Shows Signs of Lowering Biological Age in Early Clinical Study

Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery

AI Insider’s The Week in Review: OpenAI for Government, G7 Leaders, Pope Address AI, Amazon to Cut Jobs Amid AI Adoption, Plus Companies Raise Funds for Drug Discovery, Automation Across Industries

AI-designed TNIK Inhibitors Could Treat a Range of Aging-Related Diseases, From Fibrosis to Alzheimer’s.

Trending today

Italy’s Eni & Generative Bionics Partner to Explore Humanoid Robotics for Industrial Use

ElevenLabs Doubles Valuation to $22B Through $300M Employee Tender Offer

Menos AI Surpasses $10M in Total Funding as Copper Sky Capital Doubles Down

Meta Disputes Journalist’s Claim That Muse AI Agent Read Private Messages Without Consent

Reddit Ends RSS Feeds and Public API, Tightening Control Over Data Prized by AI Firms

Insilico

AI-Designed Drug Shows Signs of Lowering Biological Age in Early Clinical Study

Insilico Medicine Convenes an Open Consortium For Benchmark Quality in AI-Driven Drug Discovery

AI Insider’s The Week in Review: OpenAI for Government, G7 Leaders, Pope Address AI, Amazon to Cut Jobs Amid AI Adoption, Plus Companies Raise Funds for Drug Discovery, Automation Across Industries

AI-designed TNIK Inhibitors Could Treat a Range of Aging-Related Diseases, From Fibrosis to Alzheimer’s.

Trending today

Italy’s Eni & Generative Bionics Partner to Explore Humanoid Robotics for Industrial Use

ElevenLabs Doubles Valuation to $22B Through $300M Employee Tender Offer

Menos AI Surpasses $10M in Total Funding as Copper Sky Capital Doubles Down

Meta Disputes Journalist’s Claim That Muse AI Agent Read Private Messages Without Consent

Reddit Ends RSS Feeds and Public API, Tightening Control Over Data Prized by AI Firms

The AI economy, every weekday morning